Tapestri Platform
Clonal Resolution with Single-Cell Precision Complex disease evolves, so understanding genetic variability — including mutation co-occurrence at the single-cell level — is vitally important for clinical researchers to break the cycle of treatment response, resistance and relapse.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Clonal Resolution with Single-Cell Precision
Complex disease evolves, so understanding genetic variability — including mutation co-occurrence at the single-cell level — is vitally important for clinical researchers to break the cycle of treatment response, resistance and relapse.
Mission Bio’s Tapestri Platform used to distinguish acute myeloid leukemia clones from CHIP clones
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
Mission Bio launches pharma assay development services to speed access to new technologies
New service reduces project time from months to weeks for biopharma customers
Mission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Study using Mission Bio’s Tapestri platform reveals clonal diversity underlying AML and therapy resistance
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
19 top new resources for cancer research
Exclusive interviews, new methods, free downloads and much more to help advance your cancer research
Mission Bio partners with Agilent Technologies to advance precision medicine
This strategic partnership aims to expand access to the Tapestri Platform for single-cell multiomics
Measuring minimal residual disease related to cancer relapse with single cell genomics
Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment
Mission Bio Launches in China, Announces Distribution Partnership with Novogene
Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale
